Press Release: Solace Therapeutics, Inc. : Solace Therapeutics Announces that Florida Urology Partners Enrolls First Patient in US Pivotal Clinical Trial, using New Office-Based Treatment for Female Stress Urinary Incontinence(SUI)

TAMPA, Fla.--(BUSINESS WIRE)--Florida Urology Partners, has enrolled their first patient in the VESAIR Clinical Trial. The VESAIR Clinical Trial is being conducted in several distinguished clinics throughout the US to test the safety and efficacy of the Vesair Bladder Control Balloon procedure. "I am delighted to be participating in the VESAIR Clinical Trial. SUI is not life-threatening, but if left untreated, it can greatly diminish a woman's Quality of Life. Having a non-surgical option would